AstraZeneca to spin off anti-infectives research
Monday, March 2, 2015 - 06:10
in Physics & Chemistry
Early-stage research will transfer to a new company, while AZ and MedImmune retain late-stage programmes
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via